Researchers at the WEHI Parkinson’s Disease Research Centre have made a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery. In a major breakthrough, they have ...
Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...
Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
9h
MyChesCo on MSNAnnovis Bio to Showcase Advancements at Alzheimer’s & Parkinson’s Drug Development SummitMALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is set to participate in the 13th Alzheimer’s & Parkinson’s Drug Development ...
Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...
In the study, which was published in The BMJ, researchers analyzed data from 195 countries and territories using the 2021 ...
Researchers at Nanyang Technological University in Singapore have found a new “energy switch” in immune cells in the brain, ...
Neuroscientists at the University of Arizona have found a link between vocal changes and the aging brain in zebra finch songbirds, which could help lead to earlier diagnoses for disorders such as ...
For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...
Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results